70 related articles for article (PubMed ID: 516748)
1. [Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)].
Kovarik J; Graf H; Stummvoll HK; Wolf A; Pinggera W
Wien Klin Wochenschr; 1979 Nov; 91(22):765-8. PubMed ID: 516748
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
Hwang JC; Chen CA; Wang CT; Chen HC
Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
[TBL] [Abstract][Full Text] [Related]
5. Review of dialysate calcium concentration in hemodialysis.
Toussaint N; Cooney P; Kerr PG
Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
[TBL] [Abstract][Full Text] [Related]
6. Marked improvement in bone metabolism parameters after increasing the dialysate calcium concentration from 2.5 to 3 mEq/L in nonhypercalcemic hemodialysis patients.
Molina Vila P; Sánchez Pérez P; Garrigós Almerich E; Peris Domingo A
Hemodial Int; 2008 Jan; 12(1):73-9. PubMed ID: 18271845
[TBL] [Abstract][Full Text] [Related]
7. Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part).
Drüeke TB; Touam M
Nephrol Dial Transplant; 2009 Oct; 24(10):2990-3. PubMed ID: 19666667
[TBL] [Abstract][Full Text] [Related]
8. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.
Lezaic V; Pejanovic S; Kostic S; Pljesa S; Dimkovic N; Komadina L; Jovanovic D; Marinkovic J; Djukanovic L
Ther Apher Dial; 2007 Apr; 11(2):121-30. PubMed ID: 17381533
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients.
Saha H; Pietilä K; Mustonen J; Pasternack A; Mörsky P
Clin Nephrol; 1992 Sep; 38(3):145-8. PubMed ID: 1395167
[TBL] [Abstract][Full Text] [Related]
10. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
11. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
Izumi M; Shirai K; Ito K; Miyamoto T; Matsumoto A; Takenaka Y; Nakagawa K; Yamanashi T; Takamitsu Y; Nakanish T
Ther Apher Dial; 2005 Feb; 9(1):24-31. PubMed ID: 15828902
[TBL] [Abstract][Full Text] [Related]
12. Calcium exposure and removal in chronic hemodialysis patients.
Sigrist M; McIntyre CW
J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
[TBL] [Abstract][Full Text] [Related]
13. [Use of the equipment for hemodialysis in the diagnosis of calcium metabolism disorders in terminal chronic renal failure].
Ermakova IP; Novikov AI; Pronchenko IA; Sokolova TIu; Baeva LB; Ermolenko AE; Levitskiĭ ER
Med Tekh; 1991; (1):27-9. PubMed ID: 2038254
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
[TBL] [Abstract][Full Text] [Related]
15. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
16. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
[TBL] [Abstract][Full Text] [Related]
17. Different routes bridging calcium in Japanese hemodialysis patients.
Hamano T; Fujii N; Ito T; Imai E
Ther Apher Dial; 2005 Feb; 9(1):32-8. PubMed ID: 15828903
[TBL] [Abstract][Full Text] [Related]
18. [The effect of subtotal parathyroidectomy in patients on haemodialysis].
Vujić D; Majster Z; Lazić N; Radmirović A; Kekić Z
Srp Arh Celok Lek; 1994; 122(1-2):34-7. PubMed ID: 17972801
[TBL] [Abstract][Full Text] [Related]
19. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
Teruel JL; Nitvarro JF; Marcen R; Aguilera A; Tato A; Ottuño J
Miner Electrolyte Metab; 1997; 23(1):19-24. PubMed ID: 9058365
[TBL] [Abstract][Full Text] [Related]
20. [Peculiar problems of phosphocalcium metabolism in chronic renal insufficiency].
Drüeke T
Rev Prat; 1989 Apr; 39(11):954-8. PubMed ID: 2717868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
